Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “topiramate”

13 pharma patents match "topiramate" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 13
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 13 pharmaceutical patents matching "topiramate" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

13 results for “topiramate” · 30,257 patents in full index Clear search

  1. US 11969470

    Topiramate compositions and methods of making and using the same

    Regents of the University of Minnesota · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted

  2. US 11071787

    Topiramate compositions and methods of making and using the same

    Regents of the University of Minnesota · Granted Jul 27, 2021 · Expires Jul 22, 2041

    granted

  3. US 10314790

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  4. US 9744137

    Topiramate compositions and methods of enhancing its bioavailability

    Supernus Pharmaceuticals, Inc. · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted

  5. US 9622983

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted

  6. US 9555004

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Jan 31, 2017 · Expires Jan 26, 2037

    granted

  7. US 9549940

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Jan 24, 2017 · Expires Jan 19, 2037

    granted

  8. US 8992989

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  9. US 8889191

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  10. US 8877248

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Nov 4, 2014 · Expires Oct 30, 2034

    granted

  11. US 8663683

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Mar 4, 2014 · Expires Feb 27, 2034

    granted

  12. US 8298576

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  13. US 8298580

    Sustained-release formulations of topiramate

    Supernus Pharmaceuticals, Inc. · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.